Clinical trial Recruiting at 1 site Interventional Ages 12 to 22

Beta-band brain stimulation to reduce impulsive self-injury in teens

Official title: The Impact of Beta-band Transcranial Alternating Current Stimulation (tACS) on Impulse Inhibition in Adolescents With Non-suicidal Self-injury

Run by Anhui Medical University · NCT07152925 · Data updated 2026-11-12

This trial will try twice-daily beta-frequency transcranial alternating current stimulation versus sham in adolescents with non-suicidal self-injury to see if it reduces self-harm episodes and impulsivity and is safe.

More Depression Disorders trials

Quick facts

Study typeInterventional
Ages12 Years to 22 Years
SexAll
Enrollment60 (estimated)
SponsorAnhui Medical University
Academic / other
Locations1 site (Hefei, Anhui)
StatusRecruiting
StartedMarch 1, 2025
Main results expectedMay 31, 2026
Study endsMay 31, 2026
Registry record updatedSeptember 3, 2025
Trial IDNCT07152925 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are right-handed adolescents aged 12–18 who meet DSM-5 criteria for NSSI with at least five documented episodes and at least one incident in the past month, have sufficient education and normal or corrected binocular vision, and can participate with guardian consent.

Probably not a fit

Patients with prior suicide attempts, significant neurological conditions (e.g., epilepsy, brain surgery, intracranial metal), severe psychiatric comorbidity or substance use disorder, MoCA score below 26, or who cannot attend daily visits are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional trial compares active beta-frequency transcranial alternating current stimulation (tACS) with sham stimulation in adolescents who meet DSM-5 criteria for non-suicidal self-injury (NSSI). Participants receive two stimulation sessions per day, four hours apart, for seven consecutive days (14 sessions total), with clinical scales, behavioral tasks, and eye-tracking performed before and after the intervention. Self-injury episodes and any adverse reactions are recorded continuously, and cognitive and medical screening (e.g., MoCA, neurological history) determine eligibility. The primary outcomes focus on changes in impulse inhibition and the safety/tolerability of beta-band tACS.

Why it matters

Potential benefit: If successful, beta-band tACS could provide a short, noninvasive method to reduce impulsivity and the frequency of self-injury in adolescents.

How similar studies have gone: Small studies of noninvasive brain stimulation (tDCS/tACS) have shown mixed but occasionally promising effects on impulsivity and mood, while beta-band tACS specifically for adolescent NSSI remains a relatively novel and unproven approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 1\) Meet the proposed diagnostic criteria for non-suicidal self-injury (NSSI) in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), with ≥5 documented self-injury episodes and at least one incident within the past month as assessed by the Adolescent Non-Suicidal Self-Injury Assessment Questionnaire (ANSAQ); 2) Aged 12-18 years; 3) Right-handed; 4) Possess formal education experience sufficient to comprehend experimental protocols; 5) Normal or corrected-to-normal binocular visual acuity; 6) Voluntarily participate with legal guardians providing written informed consent.

Exclusion Criteria:

* 1\) Montreal Cognitive Assessment (MoCA) score \< 26; 2) History of suicide attempt(s); 3) Medical history of epilepsy, brain surgery, intracranial tumors, metal implants in the skull, or clinically significant head trauma; 4) History of substance use disorder, brain injury, severe somatic diseases, psychiatric disorders, or comorbid DSM-5 psychiatric conditions; 5) Prior receipt of transcranial direct current stimulation (tDCS), transcranial alternating current stimulation (tACS), or repetitive transcranial magnetic stimulation (rTMS) within the past 3 months

Where it's running

  • School of Mental Health and Psychological Sciences, Anhui Medical University
    Hefei, Anhui, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.